Nisa Investment Advisors, LLC Relmada Therapeutics, Inc. Transaction History

Nisa Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$2.17 - $35.84 $868 - $14,336	400 New	400 $1,000
Q1 2022 Apr 29, 2022	SELL	$16.72 - $26.99 $81,309 - $131,252	-4,863 Reduced 95.78%	214 $6,000
Q4 2021 Feb 03, 2022	BUY	$16.93 - $26.82 $11,021 - $17,459	651 Added 14.71%	5,077 $93,000
Q3 2021 Oct 18, 2021	SELL	$21.86 - $34.77 $10,011 - $15,924	-458 Reduced 9.38%	4,426 $116,000
Q4 2020 Jan 25, 2021	BUY	$29.88 - $39.8 $145,933 - $194,383	4,884 New	4,884 $157,000

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.9M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.